Xia Weibo

Director of the Endocrinology Department at PUMCH and China's leading authority on metabolic bone diseases. Has long focused on osteoporosis, rickets, and other bone metabolism disorders. Led his team in developing novel anti-osteoporosis drugs and established a comprehensive pharmacodynamic evaluation system covering bone mass, bone microarchitecture, and fracture risk. He has also led clinical research on multiple major anti-osteoporosis drugs in China. Whether it's complex diabetes, hyperthyroidism, or rare pituitary and adrenal diseases, his "eagle eyes" can pinpoint the root cause with precision.